Codexis Inc (CDXS)
3.61
-0.16
(-4.24%)
USD |
NASDAQ |
May 17, 16:00
3.61
0.00 (0.00%)
Pre-Market: 20:00
Codexis Cash from Financing (Quarterly): 29.28M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 29.28M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | -0.108M |
| June 30, 2023 | 6.923M |
| March 31, 2023 | 1.352M |
| December 31, 2022 | 0.339M |
| September 30, 2022 | 0.133M |
| June 30, 2022 | 0.233M |
| March 31, 2022 | -1.28M |
| December 31, 2021 | 2.426M |
| September 30, 2021 | 0.868M |
| June 30, 2021 | 0.456M |
| March 31, 2021 | 0.017M |
| December 31, 2020 | 81.59M |
| September 30, 2020 | 0.125M |
| June 30, 2020 | 0.116M |
| March 31, 2020 | -1.019M |
| December 31, 2019 | 2.422M |
| September 30, 2019 | 1.688M |
| June 30, 2019 | 51.93M |
| March 31, 2019 | -2.082M |
| December 31, 2018 | 0.251M |
| September 30, 2018 | 2.40M |
| June 30, 2018 | 38.68M |
| March 31, 2018 | -2.764M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.033M |
| September 30, 2017 | -0.12M |
| June 30, 2017 | 23.28M |
| March 31, 2017 | -1.547M |
| December 31, 2016 | 0.094M |
| September 30, 2016 | 0.077M |
| June 30, 2016 | 0.43M |
| March 31, 2016 | -1.091M |
| December 31, 2015 | 0.053M |
| September 30, 2015 | 0.039M |
| June 30, 2015 | -1.183M |
| March 31, 2015 | -0.433M |
| December 31, 2014 | 0.024M |
| September 30, 2014 | -0.354M |
| June 30, 2014 | -0.113M |
| March 31, 2014 | -0.168M |
| December 31, 2013 | -0.435M |
| September 30, 2013 | 0.007M |
| June 30, 2013 | 0.018M |
| March 31, 2013 | 0.263M |
| December 31, 2012 | 0.363M |
| September 30, 2012 | 0.607M |
| June 30, 2012 | 0.193M |
| March 31, 2012 | 0.094M |
| December 31, 2011 | 0.103M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.28M
Minimum
Mar 2022
81.59M
Maximum
Dec 2020
8.874M
Average
0.3975M
Median
Cash from Financing (Quarterly) Benchmarks
| Avidity Biosciences Inc | 389.44M |
| Taysha Gene Therapies Inc | -0.022M |
| Janux Therapeutics Inc | 322.17M |
| Tango Therapeutics Inc | 42.98M |
| 2seventy bio Inc | 0.386M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.789M |
| Cash from Investing (Quarterly) | -28.56M |
| Free Cash Flow | -54.22M |
| Free Cash Flow Per Share (Quarterly) | -0.1277 |
| Free Cash Flow to Equity (Quarterly) | -37.02M |
| Free Cash Flow to Firm (Quarterly) | -8.919M |
| Free Cash Flow Yield | -21.74% |